SCHEMBL20433740

SCHEMBL20433740

COc1cc2c(cc1OCCCOc1cc3c(cc1OC)C(=O)N1CC(O[Si](C)(C)C(C)(C)C)C[C@H]1C(=O)N3)NC(=O)[C@@H]1CCCN1C2=O

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.37
ALDH1A1 P00352 4/20 0.37
KMT2A Q03164 3/20 0.37
MAPT P10636 3/20 0.37
ALOX15 P16050 2/20 0.37
HSD17B10 Q99714 2/20 0.37
MEN1 O00255 2/20 0.37
HPGD P15428 2/20 0.37
HTR2A P28223 2/20 0.32
HTR2C P28335 2/20 0.32
HTR2B P41595 2/20 0.32
PARP1 P09874 2/20 0.32
CHEK1 O14757 1/20 0.32
MAP2K1 Q02750 1/20 0.32
GAA P10253 3/20 0.31
GABRG2 P18507 1/20 0.31
GABRB3 P28472 1/20 0.31
GABRA5 P31644 1/20 0.31
GABRA4 P48169 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17489316 0.90 POLB (0.36) KDM4EKMT2AMAPTMEN1HTR2A
SCHEMBL19035897 0.89 KDM4E (0.31) KDM4E
SCHEMBL18973168 0.89 KDM4E (0.31) KDM4E
SCHEMBL14090164 0.87 HTR2A (0.33) KDM4EALDH1A1HTR2AHTR2CHTR2B
SCHEMBL19657863 0.86 AURKA (0.34) CHEK1
SCHEMBL17476448 0.86 AURKA (0.34) CHEK1
SCHEMBL12347417 0.86
SCHEMBL22166375 0.85 POLB (0.33) KDM4E
SCHEMBL19639232 0.84 PDE4B (0.31)
SCHEMBL20169652 0.82 PDE4B (0.39) KMT2AMEN1HTR2AHTR2CHTR2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3470086-B1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF MEDIMMUNE LTD (GB) 2020-11-25 EP disclosed
EP-2906253-B1 PYRROLOBENZODIAZEPINE - ANTI-PSMA ANTIBODY CONJUGATES ADC THERAPEUTICS SA (CH) 2018-08-01 EP disclosed